EVM
GMED icon

Eaton Vance Management’s Globus Medical GMED Stock Holding History

Eaton Vance Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.55M Buy
26,067
+9,864
+61% +$594K ﹤0.01% 1128
2022
Q2 		$909K Sell
16,203
-11,456
-41% -$753K ﹤0.01% 1276
2022
Q1 		$2.04M Buy
27,659
+26,034
+1,602% +$1.81M ﹤0.01% 1169
2021
Q4 		$118K Buy
1,625
+515
+46% +$37.4K ﹤0.01% 1770
2021
Q3 		$0 Buy
1,110
+12
+1% +$963 ﹤0.01% 2292
2021
Q2 		$85K Buy
1,098
+764
+229% +$54.3K ﹤0.01% 1956
2021
Q1 		$21K Buy
+334
New +$21.2K ﹤0.01% 2061
2014
Q2 		– Sell
-161,413
Closed -$4.29M – 898
2014
Q1 		$4.29M Sell
161,413
-316
-0.2% -$7.51K 0.01% 415
2013
Q4 		$3.26M Sell
161,729
-116,851
-42% -$2.17M 0.01% 454
2013
Q3 		$4.86M Sell
278,580
-928
-0.3% -$16.1K 0.01% 374
2013
Q2 		$4.71M Buy
+279,508
New +$4.31M 0.01% 363

Other funds holding GMED

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eaton Vance Management's GMED Position: Q3 2022 in Review

Eaton Vance Management increased its Globus Medical (GMED) stake by 61% in Q3 2022, buying an estimated $594K and bringing the position to 26,067 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1128.

Eaton Vance Management first reported a position in GMED in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.86M in Q3 2013. 370 funds tracked by Wall St. Rank hold GMED as of Q3 2022.

  • Eaton Vance Management held 26,067 shares of Globus Medical worth $1.55M as of Q3 2022.
  • Eaton Vance Management bought 9,864 Globus Medical shares in Q3 2022, an estimated $594K.
  • Globus Medical made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #1128 holding.
  • Eaton Vance Management first reported a position in Globus Medical in Q2 2013 and has held it in 11 quarters since.
  • Eaton Vance Management's Globus Medical position peaked at $4.86M in Q3 2013.
  • 370 funds tracked by Wall St. Rank held Globus Medical as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.